Dose-dependent effect of mitomycin C on human vocal fold fibroblasts

Head and Neck

Volumn 36, Issue 3, 2014, Pages 401-410

  Li, Nicole Y K ^a   Chen, Fei ^b   Dikkers, Frederik G ^c   Thibeault, Susan L ^d  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

fibroblasts; larynx; mitomycin C; surgical scar; vocal folds

Indexed keywords

FIBROBLASTS; LARYNX; MITOMYCIN C; SURGICAL SCAR; VOCAL FOLDS;

ALKYLATING AGENTS; BLOTTING, WESTERN; CICATRIX; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MITOMYCIN; VOCAL CORDS; WOUND HEALING;

EID: 84894263422     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23310     Document Type: Article

References (72)

1. Talwar GP, Srivastava LM, editors. Textbook of biochemistry and human biology. New Delhi: Prentice-Hall of India Private Limited; 2004.
2. Galm U, Hager MH, Van Lanen SG, Ju J, Thorson JS, Shen B,. Antitumor antibiotics: bleomycin, enediynes, and mitomycin. Chem Rev 2005; 105: 739-758.
3. Reddy MV, Randerath K,. 32P-analysis of DNA adducts in somatic and reproductive tissues of rats treated with the anticancer antibiotic, mitomycin C. Mutat Res 1987; 179: 75-88.
4. Verweij J, Pinedo HM,. Mitomycin C: mechanism of action, usefulness and limitations. Anticancer Drugs 1990; 1: 5-13.
5. Santhiago MR, Netto MV, Wilson SE,. Mitomycin C: biological effects and use in refractive surgery. Cornea 2012; 31: 311-321.
6. Smith ME, Elstad M,. Mitomycin C and the endoscopic treatment of laryngotracheal stenosis: are two applications better than one? Laryngoscope 2009; 119: 272-283.
7. Veen EJ, Dikkers FG,. Topical use of MMC in the upper aerodigestive tract: a review on the side effects. Eur Arch Otorhinolaryngol 2010; 267: 327-334.
8. Chen SH, Feng YF, Stojanovic A, Wang QM,. Meta-analysis of clinical outcomes comparing surface ablation for correction of myopia with and without 0.02% mitomycin C. J Refract Surg 2011; 27: 530-541.
9. Teus MA, de Benito-Llopis L, Aliõ JL,. Mitomycin C in corneal refractive surgery. Surv Ophthalmol. 2009; 54: 487-502.
10. Rahbar R, Valdez TA, Shapshay SM,. Preliminary results of intraoperative mitomycin-C in the treatment and prevention of glottic and subglottic stenosis. J Voice 2000; 14: 282-286.
11. Ward RF, April MM,. Mitomycin-C in the treatment of tracheal cicatrix after tracheal reconstruction. Int J Pediatr Otorhinolaryngol 1998; 44: 221-226.
12. Cortés de Miguel S, Cabeza Barrera J, Gallardo Medina M, Cassini Gõmez de Cádiz LF, Salmerõn-García A, Rodríguez Lucas F,. Topical endotracheal mitomycin C as a complementary treatment for endoscopic treatment of recurrent laryngotracheal stenosis. Farm Hosp 2011; 35: 32-35.
13. Roediger FC, Orloff LA, Courey MS,. Adult subglottic stenosis: management with laser incisions and mitomycin-C. Laryngoscope 2008; 118: 1542-1546.
14. Roh JL, Yoon YH,. Prevention of anterior glottic stenosis after transoral microresection of glottic lesions involving the anterior commissure with mitomycin C. Laryngoscope 2005; 115: 1055-1059.
15. Hu D, Sires BS, Tong DC, Royack GA, Oda D,. Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts. Ophthal Plast Reconstr Surg 2000; 16: 119-125.
16. Ferguson B, Gray SD, Thibeault S,. Time and dose effects of mitomycin C on extracellular matrix fibroblasts and proteins. Laryngoscope 2005; 115: 110-115.
17. Rahbar R, Jones DT, Nuss RC, et al. The role of mitomycin in the prevention and treatment of scar formation in the pediatric aerodigestive tract: friend or foe? Arch Otolaryngol Head Neck Surg 2002; 128: 401-406.
18. Djordjevic B, Kim JH,. Different lethal effects of mitomycin C and actinomycin D during the division cycle of HeLa cells. J Cell Biol 1968; 38: 477-482.
19. Seong GJ, Park C, Kim CY, et al. Mitomycin-C induces the apoptosis of human Tenon's capsule fibroblast by activation of c-Jun N-terminal kinase 1 and caspase-3 protease. Invest Ophthalmol Vis Sci 2005; 46: 3545-3552.
20. Eliashar R, Eliachar I, Esclamado R, Gramlich T, Strome M,. Can topical mitomycin prevent laryngotracheal stenosis? Laryngoscope 1999; 109: 1594-1600.
21. Spector JE, Werkhaven JA, Spector NC, Huang S, Sanders D, Reinisch L,. Prevention of anterior glottic restenosis in a canine model with topical mitomycin-C. Ann Otol Rhinol Laryngol 2001; 110: 1007-1010.
22. Spector JE, Werkhaven JA, Spector NC, et al. Preservation of function and histologic appearance in the injured glottis with topical mitomycin-C. Laryngoscope 1999; 109 (7 Pt 1): 1125-1129.
23. Correa AJ, Reinisch L, Sanders DL, et al. Inhibition of subglottic stenosis with mitomycin-C in the canine model. Ann Otol Rhinol Laryngol 1999; 108 (11 Pt 1): 1053-1060.
24. Roh JL, Yoon YH,. Prevention of anterior glottic stenosis after bilateral vocal fold stripping with mitomycin C. Arch Otolaryngol Head Neck Surg 2005; 131: 690-695.
25. Roh JL,. Prevention of posterior glottic stenosis by mitomycin C. Ann Otol Rhinol Laryngol 2005; 114: 558-562.
26. Coppit G, Perkins J, Munaretto J, Nielsen R, McKinney L, Ulnick K,. The effects of mitomycin-C and stenting on airway wound healing after laryngotracheal reconstruction in a pig model. Int J Pediatr Otorhinolaryngol 2000; 53: 125-135.
27. Camargo PA, Campos AC, Matias JE, Rispoli DZ, Przysiezny PE, Fonseca VR,. Topical mitomycin C effect on swine vocal folds healing. Braz J Otorhinolaryngol 2006; 72: 601-604.
28. Pritsos CA, Sartorelli AC,. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res 1986; 46: 3528-3532.
29. Song JS, Kim JH, Yang M, Sul D, Kim HM,. Mitomycin-C concentration in cornea and aqueous humor and apoptosis in the stroma after topical mitomycin-C application: effects of mitomycin-C application time and concentration. Cornea 2007; 26: 461-467.
30. Wu KY, Wang HZ, Hong SJ,. Mechanism of mitomycin-induced apoptosis in cultured corneal endothelial cells. Mol Vis 2008; 14: 1705-1712.
31. Bell CW, Jiang W, Reich CF III, Pisetsky DS,. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 2006; 291: C1318-C1325.
32. Qin S, Wang H, Yuan R, et al. Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 2006; 203: 1637-1642.
33. Pogrebniak HW, Matthews W, Pass HI,. Chemotherapy amplifies production of tumor necrosis factor. Surgery 1991; 110: 231-237.
34. Hueman EM, Simpson CB,. Airway complications from topical mitomycin C. Otolaryngol Head Neck Surg 2005; 133: 831-835.
35. Agrawal N, Morrison GA,. Laryngeal cancer after topical mitomycin C application. J Laryngol Otol 2006; 120: 1075-1076.
36. Roh JL, Kim DH, Rha KS, Sung MW, Kim KH, Park CI,. Benefits and risks of mitomycin use in the traumatized tracheal mucosa. Otolaryngol Head Neck Surg 2007; 136: 459-463.
37. Garrett CG, Soto J, Riddick J, Billante CR, Reinisch L,. Effect of mitomycin-C on vocal fold healing in a canine model. Ann Otol Rhinol Laryngol 2001; 110: 25-30.
38. Hartnick CJ, Hartley BE, Lacy PD, et al. Topical mitomycin application after laryngotracheal reconstruction: a randomized, double-blind, placebo-controlled trial. Arch Otolaryngol Head Neck Surg 2001; 127: 1260-1264.
39. Chen X, Thibeault SL,. Characteristics of age-related changes in cultured human vocal fold fibroblasts. Laryngoscope 2008; 118: 1700-1704.
40. Chen X, Thibeault SL,. Novel isolation and biochemical characterization of immortalized fibroblasts for tissue engineering vocal fold lamina propria. Tissue Eng Part C Methods 2009; 15: 201-212.
41. Jette ME, Hayer SD, Thibeault SL,. Characterization of human vocal fold fibroblasts derived from chronic scar. Laryngoscope [In press].
42. Thibeault SL, Li W, Bartley S,. A method for identification of vocal fold lamina propria fibroblasts in culture. Otolaryngol Head Neck Surg 2008; 139: 816-822.
43. Kirsner RS, Eaglstein WH,. The wound healing process. Dermatol Clin 1993; 11: 629-640.
44. Cohen K, Diegelmann R, Lindblad W,. Wound healing: biochemical and clinical aspects. Philadelphia: W.B. Saunders; 1992.
45. Hackham DJ, Ford HR,. Cellular, biochemical, and clinical aspects of wound healing. Surg Infect (Larchmt) 2002; 3 Suppl 1: S23-S35.
46. Witte MB, Barbul A,. General principles of wound healing. Surg Clin North Am 1997; 77: 509-528.
47. Diegelmann RF, Evans MC,. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004; 9: 283-289.
48. Broughton G II, Janis JE, Attinger CE,. The basic science of wound healing. Plast Reconstr Surg 2006; 117 (7 Suppl): 12S-34S.
49. Song JS, Kim JH, Yang M, Sul D, Kim HM,. Concentrations of mitomycin C in rabbit corneal tissue and aqueous humor after topical administration. Cornea 2006; 25 (10 Suppl 1): S20-S23.
50. Pirouzian A, O'Halloran H, Scher C, Jockin Y,. Early-onset scleral and corneal ectasias following low-dose mitomycin-C-augmented trabeculectomy in a uveitic glaucoma patient. Ophthalmologica 2006; 220: 406-408.
51. Thornton I, Puri A, Xu M, Krueger RR,. Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Am J Ophthalmol 2007; 144: 673-681.
52. Thornton I, Xu M, Krueger RR,. Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia. J Refract Surg 2008; 24: S68-S76.
53. Roh DS, Cook AL, Rhee SS, et al. DNA cross-linking, double-strand breaks, and apoptosis in corneal endothelial cells after a single exposure to mitomycin C. Invest Ophthalmol Vis Sci 2008; 49: 4837-4843.
54. Gross RL,. Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid. Trans Am Ophthalmol Soc 1999; 97: 513-543.
55. Ling C, Yamashita M, Waselchuk EA, Raasch JL, Bless DM, Welham NV,. Alteration in cellular morphology, density and distribution in rat vocal fold mucosa following injury. Wound Repair Regen 2010; 18: 89-97.
56. Hansen JK, Thibeault SL,. Current understanding and review of the literature: vocal fold scarring. J Voice 2006; 20: 110-120.
57. Tateya T, Tateya I, Bless DM,. Collagen subtypes in human vocal folds. Ann Otol Rhinol Laryngol 2006; 115: 469-476.
58. Li NY, Vodovotz Y, Hebda PA, Abbott KV,. Biosimulation of inflammation and healing in surgically injured vocal folds. Ann Otol Rhinol Laryngol 2010; 119: 412-423.
59. Tateya T, Tateya I, Bless DM,. Immuno-scanning electron microscopy of collagen types I and III in human vocal fold lamina propria. Ann Otol Rhinol Laryngol 2007; 116: 156-159.
60. Tateya I, Tateya T, Lim X, Sohn JH, Bless DM,. Cell production in injured vocal folds: a rat study. Ann Otol Rhinol Laryngol 2006; 115: 135-143.
61. Tateya T, Tateya I, Sohn JH, Bless DM,. Histologic characterization of rat vocal fold scarring. Ann Otol Rhinol Laryngol 2005; 114: 183-191.
62. Tateya T, Tateya I, Sohn JH, Bless DM,. Histological study of acute vocal fold injury in a rat model. Ann Otol Rhinol Laryngol 2006; 115: 285-292.
63. Welham NV, Montequin DW, Tateya I, Tateya T, Choi SH, Bless DM,. A rat excised larynx model of vocal fold scar. J Speech Lang Hear Res 2009; 52: 1008-1020.
64. Snodgrass RG, Collier AC, Coon AE, Pritsos CA,. Mitomycin C inhibits ribosomal RNA: a novel cytotoxic mechanism for bioreductive drugs. J Biol Chem 2010; 285: 19068-19075.
65. Takahashi N, Murayama T, Oda M, Miyakoshi M,. Cell growth inhibition and DNA incorporation of mitomycin C in cell culture. Ophthalmic Res 1998; 30: 120-125.
66. Park HK, Lee KW, Choi JS, Joo CK,. Mitomycin C-induced cell death in mouse lens epithelial cells. Ophthalmic Res 2002; 34: 213-219.
67. Chen T, Kunnavatana SS, Koch RJ,. Effects of mitomycin-C on normal dermal fibroblasts. Laryngoscope 2006; 116: 514-517.
68. Occleston NL, Daniels JT, Tarnuzzer RW, et al. Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behavior. Invest Ophthalmol Vis Sci 1997; 38: 1998-2007.
69. Boerma M, Burton GR, Wang J, Fink LM, McGehee RE Jr, Hauer-Jensen M,. Comparative expression profiling in primary and immortalized endothelial cells: changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition. Blood Coagul Fibrinolysis 2006; 17: 173-180.
70. Pan C, Kumar C, Bohl S, Klingmueller U, Mann M,. Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type-specific functions. Mol Cell Proteomics 2009; 8: 443-450.
71. Kong BW, Lee JY, Bottje WG, Lassiter K, Lee J, Foster DN,. Genome-wide differential gene expression in immortalized DF-1 chicken embryo fibroblast cell line. BMC Genomics 2011; 12: 571.
72. Hirshoren N, Eliashar R,. Wound-healing modulation in upper airway stenosis-myths and facts. Head Neck 2009; 31: 111-126.